Literature DB >> 27865295

Serum Pepsinogen Levels Are Correlated With Age, Sex and the Level of Helicobacter pylori Infection in Healthy Individuals.

Rong-Gen Huang1, Hua-Long Xiao2, Bin Zhou3, Xiao-Hua Song1, Jue Zhang3, Chun-Min Wang1, Ye-Hua Jiang3, Dao-Zhen Chen4, Biao Huang5.   

Abstract

BACKGROUND: To explore the relationship between age, sex, the level of Helicobacter pylori (HP) infection and serum pepsinogen (PG) in healthy people undergoing a medical examination.
METHODS: A total of 6,596 "healthy" individuals undergoing a medical examination were selected as subjects in this study. The concentrations of serum pepsinogen I (PGI) and serum pepsinogen II (PGII) were tested for each of the subjects using time-resolved fluorescence immunoassay characterized with high sensitivity and wide measuring range. The infection ratio and level of HP were tested using a 13C-urea breath test to analyze the relationship between age, sex, HP infection, and serum PGs.
RESULTS: The PGI, PGII and PGI-to-PGII ratio (x¯±S) were higher in males than in females. The serum PGI and PGII levels gradually increased with age. HP infection rate was 48.83%, and the serum PGI, PGII and PGI-to-PGII ratio (x¯±S) were 187.05 ± 73.50µg/L, 18.09 ± 8.68µg/L and 11.67 ± 5.44, respectively in the HP-positive group and 150.39 ± 67.04µg/L, 11.50 ± 7.45µg/L and 15.67 ± 8.19, respectively in the HP-negative group. There was significant difference in the detection rate of an abnormal PG between the 2 groups as with the worsening of HP infection, 13C-urea breath test and serum PGI and PGII levels increased, but the PGI-to-PGII ratio decreased significantly.
CONCLUSIONS: Serum PGI and PGII levels were correlated with age, sex and the level of HP infection. Therefore, the influencing factors of age, sex and the level of HP infection should be considered when screening stomach diseases using PG.
Copyright © 2016 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  13C-urea breath test values; Helicobacter pylori infection; Medical examination; Pepsinogen

Mesh:

Substances:

Year:  2016        PMID: 27865295     DOI: 10.1016/j.amjms.2016.08.005

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  6 in total

1.  Factors Associated with False Negative Results in Serum Pepsinogen Testing for Precancerous Gastric Lesions in a European Population in the GISTAR Study.

Authors:  Danute Razuka-Ebela; Inese Polaka; Ilva Daugule; Sergei Parshutin; Daiga Santare; Inguna Ebela; Dace Rudzite; Reinis Vangravs; Rolando Herrero; Jin Young Park; Marcis Leja
Journal:  Diagnostics (Basel)       Date:  2022-05-07

Review 2.  Gastric Cancer Screening by Combined Determination of Serum Helicobacter pylori Antibody and Pepsinogen Concentrations: ABC Method for Gastric Cancer Screening.

Authors:  Xian-Zhe Chen; Cheng-Zhi Huang; Wei-Xian Hu; Ying Liu; Xue-Qing Yao
Journal:  Chin Med J (Engl)       Date:  2018-05-20       Impact factor: 2.628

3.  Serum pepsinogens as a gastric cancer and gastritis biomarker in South and Southeast Asian populations.

Authors:  Muhammad Miftahussurur; Langgeng Agung Waskito; Hafeza Aftab; Ratha-Korn Vilaichone; Phawinee Subsomwong; Iswan Abbas Nusi; Ari Fahrial Syam; Thawee Ratanachu-Ek; Dalla Doohan; Gontar Siregar; Yudith Annisa Ayu Rezkitha; Kartika Afrida Fauzia; Varocha Mahachai; Yoshio Yamaoka
Journal:  PLoS One       Date:  2020-04-09       Impact factor: 3.240

4.  Association of serum pepsinogens and gastrin-17 with Helicobacter pylori infection assessed by urea breath test.

Authors:  Jun-Peng Zhou; Chang-Hai Liu; Bo-Wen Liu; You-Juan Wang; Mohammed Benghezal; Barry James Marshall; Hong Tang; Hong Li
Journal:  Front Cell Infect Microbiol       Date:  2022-08-16       Impact factor: 6.073

5.  Serum pepsinogen II levels are doubled with Helicobacter pylori infection in an asymptomatic population of 40,383 Chinese subjects.

Authors:  Hong Yu; Ying Liu; Shujing Jiang; Yunfeng Zhou; Zheng Guan; Siyuan Dong; Fong-Fong Chu; Chunbo Kang; Qiang Gao
Journal:  Medicine (Baltimore)       Date:  2021-07-09       Impact factor: 1.817

6.  Screening for gastric cancer in China: Advances, challenges and visions.

Authors:  Xiaohan Fan; Xiangxiang Qin; Yang Zhang; Zhexuan Li; Tong Zhou; Jingying Zhang; Weicheng You; Wenqing Li; Kaifeng Pan
Journal:  Chin J Cancer Res       Date:  2021-04-30       Impact factor: 5.087

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.